September 8, 2020 Comments Off on Patent delisted for Veloxis Pharms drug ENVARSUS XR Posted in: Uncategorized
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post Patent delisted for Veloxis Pharms drug ENVARSUS XR appeared first on…
September 8, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug OFEV Posted in: Uncategorized
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post Patent delisted for Boehringer Ingelheim drug OFEV appeared first on…
